Diana Moore
Public Communications Contact bij AMICUS THERAPEUTICS, INC.
Profiel
Diana Moore is currently the Head-Global Communications at Amicus Therapeutics, Inc. and is also a Member at the National Investor Relations Institute.
She previously worked as the Director-Investor Relations & Business Development at Advaxis, Inc. Ms. Moore has a graduate degree from The University of Manchester and an undergraduate degree from Princeton University.
Actieve functies van Diana Moore
| Bedrijven | Functie | Begin |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Public Communications Contact | 01-10-2015 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Eerdere bekende functies van Diana Moore
| Bedrijven | Functie | Einde |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Opleiding van Diana Moore
| Princeton University | Undergraduate Degree |
| The University of Manchester | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
